Investment Q&A

Q: Thanks for the virus update. Good to get a consolidated view. Regardless of the pullback do you think semi conductors are attractive and would you prefer an ETF or a specific stock.? Thanks

Q: Hi Team,

I am thinking adding TTD. Is this a good time to buy?

Thanks!

Q: Hi guys,
What do you think of GH's quarter and the guidance provided? Prior to this weeks market decline the stock seemed to be slowly moving up. Once the COVID-19 issues are resolved and the market starts to recover, do you still see significant upside to this company and when do you think they may start showing a profit?

Q: Would starting a position in QCOM now be advisable or would you suggest letting the market stabilize before considering this?

Mike

Q: Hello,

Aside from the coronavirus jitters, was wondering if you can please comment on why Guardant Health is getting so badly pummelled after showing strong EPS and revenue in their recent earnings report. Is this an opportunity to add? Thanks.

Brad

Q: I own these 5 financial/fintech u.s. growth stocks. Thoughts on them?

Q: I own these 6 u.s. tech stocks. What are your thoughts on each?

Q: Which would be the better buy with safety and growth in mind for 3 years?
Thank You
Peter

Q: In response to the question by Satish, your suggestion was to look at tech growth stocks for a faster recovery. I had been considering TTD, NVDA, MSFT, GOOGL ,AMZN, COST and UTX before the correction; waiting for pullback. While UTX and COST have held up the others have dropped by varying degrees.
Could you please suggest your order of preference to buy in this volatile period.
As always, value your opinion.
Regards

Q: Hi 5i,

Could you rank these companies in terms of growth and stability? I'm looking for a 5+ year hold.

TIA!

Q: Your thoughts on ASML

Q: Morning guys:
Please comment on earnings .
Thx
Mark

Q: do you have any thoughts on dnr

Q: Hi Guys,

Please provide highs/lows of the most recent quarter.
Thanks

Jim

Q: Hi team,
Looking for growth, grateful for your views on DVA, MTB and CHTR. Would you buy them now ? If not, what would be better alternatives ?

Gratefully yours,

Jacques IDS

Q: Dearr 5i
What are the expected earnings growth rates for AMAT , AMD and NVDA over the next 1-2 years and which would you recommend for an RRSP assuming a balanced portfolio .
Thanks
Bill C.

Q: I just received an email from Citron talking about SDGR. They feel it is the second coming of TSLA but of course, in a different industry.
They are a brand new IPO and are up 20% today, but would this be worth purchasing in the event that it pulls back to prior to the letter and held for a period of time.
In a nutshell they recap it thusly:

"Through use of artificial intelligence and a world class scientific team that is unmatched by ANY public company, Schrodinger has created a software platform that integrates predictive physics-based methods with machine learning to become the leader in molecular simulation that 1) reduces the average time and cost required to identify a drug development candidate and 2) increases the probability of drug discovery programs entering clinical development.

With the global pharma industry spending approximately $180 billion on R&D annually, this innovative software platform is completely disrupting the drug development process."

Would you invest in this concept yourselves, once you research more about it.? I know its not a p/e , value play it may or may not be TSLA of 10 years ago.

Thanks

Sheldon

Q: Do you have a view on this company. Many years ago in a previous job I dealt with them extensively but do not recall them pushing their public company status. My experince was they tended to regularly buy out rising competitors. Looking for analysis of the key metrics.

Q: I was wondering what US stocks will do well in the short term.
-Jay

Q: Do you have a preference here or do you prefer a different semi conductor ETF? Tha nks